Heartbeam Inc (BEAT)

Mar 24, 2026

HeartBeam (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates - USA Today

Mar 24, 2026

Mar 23, 2026

HeartBeam (BEAT) director receives 44,827-share stock option grant at $1.43 - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) CFO receives stock options on 53,104 shares at $1.45 - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) awards director Richard Ferrari 50,000 RSUs - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) awards 41,380-share stock option grant to major holder - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) director awarded 20,689 RSUs, holdings rise to 95,809 shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) president receives 61,932-share stock option grant at $1.45 - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) director receives 51,724 options at $1.43 exercise price - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) director receives 17,241 RSUs in equity grant - Stock Titan

Mar 23, 2026

Mar 23, 2026

Director at HeartBeam (NASDAQ: BEAT) receives option grant for 51,724 shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

HeartBeam (BEAT) president receives 55,172 stock options as equity grant - Stock Titan

Mar 23, 2026

Mar 22, 2026

Aug Opening: Can HeartBeam Inc outperform in the next rallyTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn

Mar 22, 2026

Mar 22, 2026

Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN

Mar 22, 2026

Mar 21, 2026

If You Invested $1,000 in Heartbeam Inc (BEAT) - Stock Titan

Mar 21, 2026

Mar 21, 2026

HeartBeam announces first patient enrollments in heart attack detection pilot study - MSN

Mar 21, 2026

Mar 20, 2026

HeartBeam : Earnings Documents - marketscreener.com

Mar 20, 2026

Mar 20, 2026

HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today

Mar 20, 2026

Mar 20, 2026

BEAT Stock Price, Quote & Chart | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill

Mar 20, 2026

Mar 18, 2026

Aug Catalysts: Is HeartBeam Inc Equity Warrant benefiting from interest rate changesMarket Activity Report & Community Trade Idea Sharing - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

Trend Recap: Is HeartBeam Inc a turnaround storyWeekly Trade Summary & Low Risk High Reward Ideas - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail

Mar 17, 2026

Mar 17, 2026

H.C. Wainwright reiterates Heartbeam stock rating on commercial progress By Investing.com - Investing.com India

Mar 17, 2026

Mar 17, 2026

H.C. Wainwright reiterates Heartbeam stock rating on commercial progress - Investing.com

Mar 17, 2026

Mar 17, 2026

Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2026

Mar 17, 2026

HeartBeam Shares Fall After Benchmark Maintains Speculative Buy Rating - marketscreener.com

Mar 17, 2026

Mar 17, 2026

Benchmark Maintains HeartBeam's Rating at Speculative Buy, Price Target is $8 - marketscreener.com

Mar 17, 2026

Mar 16, 2026

HeartBeam Shares Fall After Benchmark Downgrade - marketscreener.com

Mar 16, 2026

Mar 16, 2026

HeartBeam partners with Mount Sinai to advance AI-powered ECG technology - MSN

Mar 16, 2026

Mar 16, 2026

Benchmark Downgrades HeartBeam to Speculative Buy From Buy, Price Target is $8 - marketscreener.com

Mar 16, 2026

Mar 15, 2026

HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - USA Today

Mar 15, 2026

Mar 15, 2026

HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today

Mar 15, 2026

Mar 15, 2026

HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com

Mar 15, 2026

Mar 15, 2026

HeartBeam to present at March investor conferences By Investing.com - Investing.com Nigeria

Mar 15, 2026

Mar 14, 2026

HeartBeam reports net loss of USD 5.3M in Q4 2025 - Medical Buyer

Mar 14, 2026

Mar 13, 2026

HeartBeam Earnings Call Balances Breakthroughs With Cash Risk - TipRanks

Mar 13, 2026

Mar 13, 2026

HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch By Investing.com - Investing.com Australia

Mar 13, 2026

Mar 13, 2026

HeartBeam (NASDAQ: BEAT) files $100M shelf; $78.8M previously registered unsold - Stock Titan

Mar 13, 2026

Mar 13, 2026

HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - NewMediaWire

Mar 13, 2026

Mar 13, 2026

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 13, 2026

Mar 13, 2026

HeartBeam, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 13, 2026

Mar 13, 2026

Precision Neuroscience, founded by Neuralink alums, is developing a competing brain implant that it says is safer - AOL.com

Mar 13, 2026

Mar 12, 2026

HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India

Mar 12, 2026

Mar 12, 2026

Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com Nigeria

Mar 12, 2026

Mar 12, 2026

HeartBeam Q4 2025 Earnings Call Transcript - MarketBeat

Mar 12, 2026

Mar 12, 2026

HeartBeam, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-03-12 - Seeking Alpha

Mar 12, 2026